Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Equity Raises:
- On February 12, 2025, Vitura Health Limited (VIT: AUX), an Australian seller and distributor of medical cannabis products and operator of medicinal cannabis clinics, closed an equity private placement for gross proceeds of approximately $3.24M.
- The company sold 74.8M shares at $.043 per share.
- Proceeds will fund the cash portion of Vitura’s acquisition of Candor Medical Pty Ltd.
Public vs. Private Raises:
- Both capital raisers this week are public companies—one trades in Australia on the AUX, and the other trades on Nasdaq.
Equity vs. Debt Cap Raises:
- Debt accounted for 59% of trailing 8-week capital raises primarily because of the significant VIREO stock issue. The ratio may go down if companies are able to utilize favorable regulatory-induced stock price increases to complete equity issues. However, equity pricing has remained stubbornly low while the cannabis debt capital markets have reopened.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.